Bookmark and Share

Hot Stock; Orexigen Therapeutics Inc. (OREX)

Shares of Orexigen Therapeutics Inc. (NASDAQ: OREX), a biopharmaceutical company engaged in the development of pharmaceutical product candidates for the treatment of obesity, soared in trading on Thursday.

OREX shares rose to a new 52-week high of $5.95 on Thursday before finishing the day 19.92% higher at $5.90 on above average volume of 22.47 million. The stock gained 45.5% in the last three trading sessions.

Orexigen Therapeutics shares have been gaining momentum after the FDA approved Arena Pharmaceuticals Inc.’s (NASDAQ: ARNA) obesity drug Belviq.

The approval has raised prospects for Orexigen’s own obesity drug, Contrave. It may be recalled that the FDA initially rejected both, Contrave and Belviq, due to safety concerns. But, the approval of Belviq has given hope to OREX.

Orexigen plans to refile its application with additional safety data for Contrave within two years.


Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.